Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia

Amnestic mild cognitive impairment (MCI) is a prodromal stage of dementia, with a higher incidence of these patients progressing to Alzheimer’s disease (AD) than normal aging people. A biomarker for the early detection and prediction for this progression is important. We recruited MCI subjects in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tien, Yi-Ting, Lee, Wei-Ju, Liao, Yi-Chu, Wang, Wen-Fu, Jhang, Kai-Ming, Wang, Shuu-Jiun, Fuh, Jong-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904474/
https://www.ncbi.nlm.nih.gov/pubmed/31822765
http://dx.doi.org/10.1038/s41598-019-55318-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904474/
https://www.ncbi.nlm.nih.gov/pubmed/31822765
http://dx.doi.org/10.1038/s41598-019-55318-0

Ejemplares similares